☆ 4.2 Article

Catastrophic antiphospholipid syndrome in an immune thrombocytopenia patient treated with avatrombopag

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Oncology

Risk of thrombosis with thrombopoietin receptor agonists for ITP patients: A review and meta

Mathilde Tjepkema et al.

Summary: This study aimed to review whether patients with immune thrombocytopenia (ITP) treated with thrombopoietin receptor agonists (TPO-RA) have a higher risk of thrombosis compared to ITP patients without TPO-RA treatment. The analysis included 11 studies, and although more thromboembolic events were observed in the TPO-RA group, the individual risk ratios were not statistically significant. The meta-analysis showed a non-significant higher chance of thrombosis in ITP patients with TPO-RA treatment.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Catastrophic anti-phospholipid syndrome with Libman-Sacks endocarditis following eltrombopag therapy for immune thrombocytopenic purpura: A case report

Sara Dichtwald et al.

Summary: ITP is an autoimmune disease characterized by accelerated platelet destruction, commonly treated with glucocorticoids and intravenous immunoglobulins. In refractory cases, drugs that enhance thrombopoiesis like Eltrombopag may be used. However, thrombotic adverse events, potentially life-threatening, can occur with Eltrombopag, especially in high-risk patients.

LUPUS (2021)

添加到收藏夹

Review Hematology

Thrombosis in immune thrombocytopenia - current status and future perspectives

Dawn Swan et al.

Summary: Patients with immune thrombocytopenia (ITP) are at increased risk of developing venous and arterial thrombotic events, despite the primary aim of therapy being the prevention of bleeding. Limited evidence is available to guide clinicians in treating these complex cases.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?

Riccardo Tomasello et al.

Summary: Antiphospholipid syndrome (APS) is often linked with mild thrombocytopenia, while some patients may develop secondary immune thrombocytopenia (ITP) leading to severe thrombocytopenia with risks of major bleeding. It is important to assess the presence of antiphospholipid antibodies (aPL) in patients with ITP to stratify the risk of thrombosis and to define appropriate treatment strategies.

BIOMEDICINES (2021)

添加到收藏夹

Review Hematology

Treatment of Vascular Thrombosis in Antiphospholipid Syndrome: An Update

Lida Kalmanti et al.

HAMOSTASEOLOGIE (2020)

添加到收藏夹

Review Hematology

Thrombopoietin receptor agonists: ten years later

Waleed Ghanima et al.

HAEMATOLOGICA (2019)

添加到收藏夹

Review Hematology

Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Drew Provan et al.

BLOOD ADVANCES (2019)

添加到收藏夹

Review Medicine, General & Internal

Diagnosis and Management of the Antiphospholipid Syndrome

David Garcia et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Medicine, General & Internal

Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria

Rosalia Demetrio Pablo et al.

MEDICINA CLINICA (2017)

添加到收藏夹

Review Hematology

Diagnosis and management of the antiphospholipid syndrome

Shruti Chaturvedi et al.

BLOOD REVIEWS (2017)

添加到收藏夹

Article Rheumatology

Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostim, a thrombopoietin receptor agonist

Brian LaMoreaux et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)

添加到收藏夹

Review Hematology

The hematologic manifestations of the antiphospholipid syndrome

Imad Uthman et al.

BLOOD REVIEWS (2008)

添加到收藏夹

Article Immunology

Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry

Ricard Cervera et al.

AUTOIMMUNITY REVIEWS (2006)

添加到收藏夹

Article Hematology

Anti phospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS)

Carlos J. Bidot et al.

AMERICAN JOURNAL OF HEMATOLOGY (2006)

添加到收藏夹

Review Hematology

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

S Miyakis et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)

添加到收藏夹

Article Hematology

Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura:: a prospective cohort study

R Diz-Küçükkaya et al.

BLOOD (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.